X Square Capital LLC bought a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 23,025 shares of the company's stock, valued at approximately $1,243,000. X Square Capital LLC owned 0.25% of Semler Scientific as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. Global Retirement Partners LLC lifted its position in shares of Semler Scientific by 62.5% during the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock worth $70,000 after purchasing an additional 500 shares during the last quarter. Sanctuary Advisors LLC boosted its position in shares of Semler Scientific by 13.2% during the 4th quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock worth $261,000 after acquiring an additional 584 shares in the last quarter. Jones Financial Companies Lllp acquired a new position in Semler Scientific in the fourth quarter valued at approximately $34,000. Larson Financial Group LLC acquired a new stake in Semler Scientific during the fourth quarter worth approximately $38,000. Finally, State Street Corp increased its position in shares of Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company's stock worth $2,784,000 after purchasing an additional 725 shares in the last quarter. Institutional investors and hedge funds own 49.37% of the company's stock.
Semler Scientific Stock Up 2.0 %
NASDAQ SMLR traded up $0.73 during trading hours on Tuesday, hitting $36.93. 67,431 shares of the stock were exchanged, compared to its average volume of 386,150. The stock has a 50-day moving average of $44.90 and a 200 day moving average of $45.00. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56. The company has a market cap of $354.44 million, a price-to-earnings ratio of 7.52 and a beta of 1.33.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.
Wall Street Analysts Forecast Growth
Separately, Lake Street Capital lifted their price objective on shares of Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a research report on Friday, January 24th.
Get Our Latest Analysis on Semler Scientific
Semler Scientific Company Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles

Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.